Biosensing platform shows rapid, sensitive detection of dopamine in whole blood, suggesting advancements in medical diagnostics.
We demonstrate a biosensing platform featuring a plasmonic “aptasensor”, that can perform rapid, sensitive, and selective detection of the neurotransmitter dopamine in various biological fluids including whole blood, potentially revolutionizing medical diagnostics and disease monitoring.
No takes yet. Share an insight, caveat, or question.
Biswas et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: